SLC16A14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.386020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.178800E-01
Normal-vs-Stage2
1.484990E-01
Normal-vs-Stage3
1.108600E-01
Normal-vs-Stage4
2.037200E-01
Stage1-vs-Stage2
7.153800E-01
Stage1-vs-Stage3
3.940000E-01
Stage1-vs-Stage4
8.361800E-01
Stage2-vs-Stage3
6.087800E-01
Stage2-vs-Stage4
9.092600E-01
Stage3-vs-Stage4
5.353800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.036040E-01
Normal-vs-AfricanAmerican
8.912000E-01
Normal-vs-Asian
1.248640E-01
Caucasian-vs-AfricanAmerican
3.569200E-01
Caucasian-vs-Asian
8.821800E-01
AfricanAmerican-vs-Asian
3.969600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.444240E-01
Normal-vs-Female
1.479770E-01
Male-vs-Female
7.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.697800E-01
Normal-vs-Age(41-60Yrs)
4.109400E-01
Normal-vs-Age(61-80Yrs)
7.396200E-02
Normal-vs-Age(81-100Yrs)
9.337100E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.205400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.486600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.884600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.354460E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.762400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.187200E-01
Normal-vs-Daily Drinker
9.220400E-03
Normal-vs-Weekly Drinker
1.689660E-02
Normal-vs-Occasional Drinker
2.169600E-01
Normal-vs-Social Drinker
2.287800E-01
Non Drinker-vs-Daily Drinker
2.595200E-01
Non Drinker-vs-Weekly Drinker
6.424600E-01
Non Drinker-vs-Occasional Drinker
8.302200E-01
Non Drinker-vs-Social Drinker
8.153600E-01
Daily Drinker-vs-Weekly Drinker
4.212800E-01
Daily Drinker-vs-Occasional Drinker
1.794380E-01
Daily Drinker-vs-Social Drinker
1.791020E-01
Weekly Drinker-vs-Occasional Drinker
4.981200E-01
Weekly Drinker-vs-Social Drinker
5.030600E-01
Occasional Drinker-vs-Social Drinker
9.745400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.785830E-01
Normal-vs-Grade 2
1.339440E-01
Normal-vs-Grade 3
2.037400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.850000E-01
Grade 1-vs-Grade 3
3.090200E-01
Grade 1-vs-Grade 4
1.785830E-01
Grade 2-vs-Grade 3
8.260200E-01
Grade 2-vs-Grade 4
1.339440E-01
Grade 3-vs-Grade 4
2.037400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.178420E-02
Normal-vs-NonDiabetic
1.400600E-01
Diabetic-vs-NonDiabetic
1.808830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.023370E-03
Normal-vs-NoPancreatitis
1.229450E-01
Pancreatitis-vs-NoPancreatitis
1.652190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.055900E-02
Normal-vs-N1
1.679440E-01
N0-vs-N1
3.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.382300E-02
Normal-vs-TP53-NonMutant
2.153200E-01
TP53-Mutant-vs-TP53-NonMutant
4.271700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
